TipRanks
MetaLabs Co., Ltd. (KR:090370)
:090370
South Korea Market
Want to see KR:090370 full AI Analyst Report?

MetaLabs Co., Ltd. (090370) AI Stock Analysis

― Followers

Top Page

KR:090370

MetaLabs Co., Ltd.

(090370)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - Gpt-5.6Sol)
Rating:46Neutral
Price Target:
₩1,020.00
Action:N/A
Date:10/28/26
The score is held back primarily by weak profitability and rising leverage despite improving revenue growth and a return to positive operating/free cash flow. Technicals are also negative with price below major moving averages and bearish momentum, while valuation is constrained by a negative P/E and no dividend yield data.
Positive Factors
Revenue Growth
Revenue growth provides evidence that demand or commercial activity is expanding despite the company’s weak current profitability. If this momentum persists, it can improve operating leverage, support greater scale, and create a foundation for restoring positive earnings over the next several quarters.
Negative Factors
Persistent Losses and Low Margins
Low gross profitability and continued operating losses show that revenue growth is not yet translating into durable earnings power. This limits self-funded expansion, leaves less room to absorb cost pressure, and makes the company’s recovery dependent on sustained operational improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Revenue growth provides evidence that demand or commercial activity is expanding despite the company’s weak current profitability. If this momentum persists, it can improve operating leverage, support greater scale, and create a foundation for restoring positive earnings over the next several quarters.
Read all positive factors

MetaLabs Co., Ltd. (090370) vs. SPDR S&P 500 ETF (SPY)

MetaLabs Co., Ltd. Business Overview & Revenue Model

Company Description
Metalabs Co., Ltd. primarily engages in the supply of clothing across South Korea. Its operations are multifaceted, also encompassing the manufacturing and distribution of pharmaceutical drugs, medical devices, and masks. The company further dedic...

MetaLabs Co., Ltd. Financial Statement Overview

Summary
Revenue is growing strongly (TTM +15.4%) and cash flow improved to positive operating and free cash flow, but profitability remains weak with negative operating profit and net margin (~-4.9%). Balance-sheet risk has increased as leverage rose to ~1.18 debt-to-equity, and returns remain negative, indicating a turnaround in progress but still below-average earnings quality.
Income Statement
34
Negative
Balance Sheet
45
Neutral
Cash Flow
56
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue119.18B81.39B38.36B21.60B22.66B39.30B
Gross Profit16.94B8.02B8.90B4.36B9.61B20.27B
EBITDA496.15M-3.79B3.21B-3.79B-8.47B-13.52B
Net Income-5.90B-8.79B196.94M-7.30B-12.81B-16.20B
Balance Sheet
Total Assets293.67B249.95B133.24B111.86B90.02B85.03B
Cash, Cash Equivalents and Short-Term Investments12.43B4.16B1.70B1.72B17.14B20.79B
Total Debt102.12B87.33B42.61B31.64B5.29B11.61B
Total Liabilities137.95B108.13B53.79B38.45B11.13B28.60B
Stockholders Equity86.30B69.93B78.14B71.84B78.68B52.02B
Cash Flow
Free Cash Flow2.71B-3.79B-4.61B-541.15M-2.12B1.87B
Operating Cash Flow3.47B-2.50B-3.83B-49.57M447.64M2.28B
Investing Cash Flow1.61B7.92B-12.66B-27.25B-27.95B-20.70B
Financing Cash Flow-2.70B-3.06B16.52B26.93B18.34B26.29B

MetaLabs Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price―
Price Trends
50DMA
1144.00
Negative
100DMA
1115.55
Negative
200DMA
1309.47
Negative
Market Momentum
MACD
-34.65
Positive
RSI
25.55
Positive
STOCH
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:090370, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 1110.05, equal to the 50-day MA of 1144.00, and equal to the 200-day MA of 1309.47, indicating a bearish trend. The MACD of -34.65 indicates Positive momentum. The RSI at 25.55 is Positive, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:090370.

MetaLabs Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
₩2.31T4.47―4.39%6.80%56.37%
72
Outperform
₩2.88T5.48―3.62%15.31%60.02%
62
Neutral
₩276.94B13.00―1.11%4.93%26.97%
61
Neutral
₩576.36B5.05―3.27%-0.14%36.70%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
50
Neutral
₩325.70B9.22―7.26%7.87%-28.36%
46
Neutral
₩27.77B-4.54―0.53%203.49%-57.36%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
KR:090370
MetaLabs Co., Ltd.
1,017.00
-973.00
-48.89%
KR:001460
BYC Co., Ltd
36,150.00
293.54
0.82%
KR:093050
LF Corp.
21,400.00
3,641.65
20.51%
KR:105630
Hansae Co., Ltd
8,270.00
-1,675.57
-16.85%
KR:111770
Youngone Corp.
67,700.00
10,587.54
18.54%
KR:383220
F&F Co., Ltd.
61,500.00
1,700.00
2.84%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 28, 2026